Goldman Sachs
IMA

Goldman Sachs’s ImageneBio Inc IMA Stock Holding History

Goldman Sachs’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.3K Buy
11,458
+508
+5% +$3.3K ﹤0.01% 6286
2025
Q4 		$75.6K Buy
+10,950
New +$81.2K ﹤0.01% 6238
2025
Q3 		– Sell
-5,555
Closed -$89.3K – 6488
2025
Q2 		$89.3K Sell
5,555
-817
-13% -$12K ﹤0.01% 5839
2025
Q1 		$97.9K Buy
6,372
+2,447
+62% +$42.2K ﹤0.01% 5789
2024
Q4 		$77.2K Sell
3,925
-960
-20% -$19.4K ﹤0.01% 5804
2024
Q3 		$101K Sell
4,885
-17,935
-79% -$363K ﹤0.01% 5568
2024
Q2 		$452K Buy
22,820
+16,770
+277% +$296K ﹤0.01% 4888
2024
Q1 		$103K Buy
6,050
+4,084
+208% +$74.4K ﹤0.01% 5244
2023
Q4 		$46.5K Buy
1,966
+184
+10% +$6K ﹤0.01% 5383
2023
Q3 		$92.6K Buy
1,782
+303
+20% +$18.2K ﹤0.01% 5195
2023
Q2 		$116K Sell
1,479
-1,454
-50% -$104K ﹤0.01% 5332
2023
Q1 		$121K Buy
+2,933
New +$135K ﹤0.01% 5423
2022
Q4 		– Sell
-1,036
Closed -$44K – 6125
2022
Q3 		$44K Sell
1,036
-928
-47% -$53.7K ﹤0.01% 5818
2022
Q2 		$105K Sell
1,964
-213
-10% -$11.8K ﹤0.01% 5845
2022
Q1 		$160K Buy
2,177
+1,105
+103% +$117K ﹤0.01% 5954
2021
Q4 		$161K Buy
+1,072
New +$174K ﹤0.01% 5982
2021
Q2 		– Sell
-3,258
Closed -$1.1M – 6354
2021
Q1 		$1.1M Buy
+3,258
New +$1.12M ﹤0.01% 4528

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs's IMA Position: Q1 2026 in Review

Goldman Sachs increased its ImageneBio Inc (IMA) stake by 4.6% in Q1 2026, buying an estimated $3.3K and bringing the position to 11,458 shares worth $57.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6286.

Goldman Sachs first reported a position in IMA in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.1M in Q1 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Goldman Sachs held 11,458 shares of ImageneBio Inc worth $57.3K as of Q1 2026.
  • Goldman Sachs bought 508 ImageneBio Inc shares in Q1 2026, an estimated $3.3K.
  • ImageneBio Inc made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6286 holding.
  • Goldman Sachs first reported a position in ImageneBio Inc in Q1 2021 and has held it in 17 quarters since.
  • Goldman Sachs's ImageneBio Inc position peaked at $1.1M in Q1 2021.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.